Ngā hua rapu - Bernard A. Callus

  • E whakaatu ana i te 1 - 11 hua o te 11
Whakamahine hua
  1. 1
    Caspase inhibitors: viral, cellular and chemical

    Caspase inhibitors: viral, cellular and chemical mā Bernard A. Callus, David L. Vaux

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Regulation of microRNAs and their role in liver development, regeneration and disease

    Regulation of microRNAs and their role in liver development, regeneration and disease mā Megan Finch‐Edmondson, Jens U. Marquardt, George C. Yeoh, Bernard A. Callus

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells

    TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells mā Megan Finch‐Edmondson, Robyn P. Strauss, Adam M. Passman, Marius Sudol, George C. Yeoh, Bernard A. Callus

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Mature DIABLO/Smac Is Produced by the IMP Protease Complex on the Mitochondrial Inner Membrane

    Mature DIABLO/Smac Is Produced by the IMP Protease Complex on the Mitochondrial Inner Membrane mā Lena Burri, Yvan Strahm, Christine J. Hawkins, Ian E. Gentle, Michelle Puryer, Anne M. Verhagen, Bernard A. Callus, David L. Vaux, Trevor Lithgow

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound

    Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound mā Matthew M. Jellicoe, Scott J. Nichols, Bernard A. Callus, Murray V. Baker, Peter J. Barnard, Susan J. Berners‐Price, James Whelan, George C. Yeoh, Aleksandra Filipovska

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim

    Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim mā Anissa M. Jabbour, Jacki Heraud-Farlow, Carmel Daunt, Thomas Kaufmann, J. Sandow, Lorraine A. O’Reilly, Bernard A. Callus, Angel F. López, Andreas Strasser, David L. Vaux, Paul G. Ekert

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors

    Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors mā Oliver Rackham, Anne-Marie J. Shearwood, Ross Thyer, Elyshia McNamara, Stefan M.K. Davies, Bernard A. Callus, Antonio Miranda‐Vizuete, Susan J. Berners‐Price, Qing Cheng, Elias S.J. Arnér, Aleksandra Filipovska

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma

    Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma mā Paul G. Ekert, Anissa M. Jabbour, Anand Manoharan, Jacki Heraud-Farlow, Jai Y. Yu, Miha Pakusch, Ewa M. Michalak, Priscilla N. Kelly, Bernard A. Callus, Thomas Kiefer, Anne M. Verhagen, John Silke, Andreas Strasser, Christoph Borner, David L. Vaux

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα

    TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα mā James E. Vince, Diep Chau, Bernard A. Callus, W. Wei‐Lynn Wong, Christine J. Hawkins, Pascal Schneider, Mark A. McKinlay, Christopher A. Benetatos, Stephen M. Condon, Srinivas K. Chunduru, George C. Yeoh, Robert Brink, David L. Vaux, John Silke

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis

    TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis mā James E. Vince, Delara Pantaki, Rebecca Feltham, Peter D. Mace, Stephanie M. Cordier, Anna C. Schmukle, Angelina J. Davidson, Bernard A. Callus, W. Wei‐Lynn Wong, Ian E. Gentle, Holly Carter, Erinna F. Lee, Henning Walczak, Catherine L. Day, David L. Vaux, John Silke

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

    IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis mā James E. Vince, W. Wei‐Lynn Wong, Nufail Khan, Rebecca Feltham, Diep Chau, Afsar U. Ahmed, Christopher A. Benetatos, Srinivas K. Chunduru, Stephen M. Condon, Mark A. McKinlay, Robert Brink, Martin Leverkus, Vinay Tergaonkar, Pascal Schneider, Bernard A. Callus, Frank Köentgen, David L. Vaux, John Silke

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: